drugset / Trial / NCT00513643
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
Phase 1
Completed
16 enrolled
Profil Institute for Metabolic Research GmbH
Novo Nordisk A/S · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The metabolic effect of three different doses of insulin aspart and human insulin are investigated with the euglycaemic glucose clamp technique.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | 6 iu | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | 12 iu | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | 24 iu | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | 6 iu | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | 12 iu | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | 24 iu | Subcutaneous |